FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1650596887> ?p ?o ?g. }

• W1650596887 abstract "Abstract 1557 Poster Board I-580 Introduction The CC thymus and activation related chemokine TARC, a protein highly expressed by Reed-Sternberg cells and in the microenvironment of Hodgkin9s lymphoma (HL) involved lymph nodes, as well as detectable in the serum of HL patients (pts), has been reported to have prognostic value in retrospective analysis. The aim of our study was to prospectively investigate the association among PET-2 results and TARC serum levels (T) in HL and the prognostic role of T in disease relapse or progression. Patients and Methods Between November 2006 and June 2009, T was measured by ELISA in 73 pts: 50 newly diagnosed untreated pts (Group U) and 23 pts relapsing or progressing after first line CT±RT (Group S). Group U pts received stage-directed therapy consisting in 4 ABVD cycles followed by IFRT for stage I-II A, and 6-8 ABVD cycles ± RT on bulky sites of disease for stage II B, III-IV. Group S pts received cytoreductive CT with Ifosfamide-containing regimens followed by HDBEAM+ASCT. T evaluation was repeated after each CT cycle, at the end of treatment and during follow-up. Results Main pts characteristics were as follows: males/females: 32/41; age 3/≤3 involved sites: 34/39; IPS>2/≤2: 8/65. Basal T (T0) (median, IQ range) was significantly higher in Group U vs S (23540, 6528-50710 vs 1448, 735-8278; Mann-Whitney test P=0.002); T0 values >536 were observed in 43 (86%) Group U pts and 18 (78%) Group S pts (536 was the 95th centile of T distribution in a group of 40 independent healthy subjects). Pts with NS, bulky disease and extranodal involvement had significantly higher T0 levels than their counterparts. After 2 CT cycles, T (T2) was significantly lower than T0 in Group U (Wilcoxon paired sample test P 536 were observed in 18 (36%) Group U pts and 14 (61%) Group S pts. PET-2 scan was positive in 20 pts (27%) (Group U: 18%, Group S: 48%); PET- 2 was positive in 19/61 pts (31%) with T0 >536 and in 1/12 pts (8%) with T0 ≤ 536; in 17/32 (53%) pts with T2 >536 and in 2/35 (6%) pts with T2 ≤ 536. The chance of having a positive PET-2 was similar in pts with T0 >536 and T2 ≤ 536 compared with pts with T0 ≤ 536 (OR: 1.1; 95% CI: 0.9-13.5), whereas it was 13-fold greater in pts with both T0 and T2 >536 (OR: 12.6; 95% CI 1.4-110). Median follow-up was 18 months (interquartile range: 13-25 months); 13 (18%) pts had relapse or progression (7 Group U, 6 Group S), 24-months progression-free survival (PFS) was 83.4% in Group U and 60.6% in Group S. PFS was 100% vs 78.6% vs 59.4% in pts with T0 ≤ 536, T0 >536 and T2 ≤ 563, and both T0 and T2 >536, respectively. Conclusions Our study confirms that HL pts have increased serum TARC values at baseline compared with healthy subjects; moreover T0 combined with values observed after 2 cycles of CT may have a role in predicting PET-2 results and disease outcome. Disclosures No relevant conflicts of interest to declare." @default.
• W1650596887 created "2016-06-24" @default.
• W1650596887 creator A5018411752 @default.
• W1650596887 creator A5025152199 @default.
• W1650596887 creator A5030934542 @default.
• W1650596887 creator A5044146626 @default.
• W1650596887 creator A5053586777 @default.
• W1650596887 creator A5080000609 @default.
• W1650596887 creator A5083523436 @default.
• W1650596887 creator A5087990801 @default.
• W1650596887 creator A5090715927 @default.
• W1650596887 date "2010-03-31" @default.
• W1650596887 modified "2023-09-28" @default.
• W1650596887 title "TARC is useful as additional prognostic factor for Hodgkin's lymphoma outcome" @default.
• W1650596887 doi "https://doi.org/10.7490/f1000research.146.1" @default.
• W1650596887 hasPublicationYear "2010" @default.
• W1650596887 type Work @default.
• W1650596887 sameAs 1650596887 @default.
• W1650596887 citedByCount "0" @default.
• W1650596887 crossrefType "journal-article" @default.
• W1650596887 hasAuthorship W1650596887A5018411752 @default.
• W1650596887 hasAuthorship W1650596887A5025152199 @default.
• W1650596887 hasAuthorship W1650596887A5030934542 @default.
• W1650596887 hasAuthorship W1650596887A5044146626 @default.
• W1650596887 hasAuthorship W1650596887A5053586777 @default.
• W1650596887 hasAuthorship W1650596887A5080000609 @default.
• W1650596887 hasAuthorship W1650596887A5083523436 @default.
• W1650596887 hasAuthorship W1650596887A5087990801 @default.
• W1650596887 hasAuthorship W1650596887A5090715927 @default.
• W1650596887 hasConcept C126322002 @default.
• W1650596887 hasConcept C143998085 @default.
• W1650596887 hasConcept C146357865 @default.
• W1650596887 hasConcept C151730666 @default.
• W1650596887 hasConcept C2776305933 @default.
• W1650596887 hasConcept C2776694085 @default.
• W1650596887 hasConcept C2776755627 @default.
• W1650596887 hasConcept C2779020855 @default.
• W1650596887 hasConcept C2779338263 @default.
• W1650596887 hasConcept C2779429289 @default.
• W1650596887 hasConcept C2992779791 @default.
• W1650596887 hasConcept C71924100 @default.
• W1650596887 hasConcept C86803240 @default.
• W1650596887 hasConcept C90924648 @default.
• W1650596887 hasConceptScore W1650596887C126322002 @default.
• W1650596887 hasConceptScore W1650596887C143998085 @default.
• W1650596887 hasConceptScore W1650596887C146357865 @default.
• W1650596887 hasConceptScore W1650596887C151730666 @default.
• W1650596887 hasConceptScore W1650596887C2776305933 @default.
• W1650596887 hasConceptScore W1650596887C2776694085 @default.
• W1650596887 hasConceptScore W1650596887C2776755627 @default.
• W1650596887 hasConceptScore W1650596887C2779020855 @default.
• W1650596887 hasConceptScore W1650596887C2779338263 @default.
• W1650596887 hasConceptScore W1650596887C2779429289 @default.
• W1650596887 hasConceptScore W1650596887C2992779791 @default.
• W1650596887 hasConceptScore W1650596887C71924100 @default.
• W1650596887 hasConceptScore W1650596887C86803240 @default.
• W1650596887 hasConceptScore W1650596887C90924648 @default.
• W1650596887 hasLocation W16505968871 @default.
• W1650596887 hasOpenAccess W1650596887 @default.
• W1650596887 hasPrimaryLocation W16505968871 @default.
• W1650596887 hasRelatedWork W2279042374 @default.
• W1650596887 hasRelatedWork W2476878773 @default.
• W1650596887 hasRelatedWork W2570052812 @default.
• W1650596887 hasRelatedWork W2572026863 @default.
• W1650596887 hasRelatedWork W2576564387 @default.
• W1650596887 hasRelatedWork W2578565664 @default.
• W1650596887 hasRelatedWork W2582014052 @default.
• W1650596887 hasRelatedWork W2584378227 @default.
• W1650596887 hasRelatedWork W2586573469 @default.
• W1650596887 hasRelatedWork W2591261245 @default.
• W1650596887 hasRelatedWork W2594131847 @default.
• W1650596887 hasRelatedWork W26452364 @default.
• W1650596887 hasRelatedWork W2944078777 @default.
• W1650596887 hasRelatedWork W2969065704 @default.
• W1650596887 hasRelatedWork W2979317294 @default.
• W1650596887 hasRelatedWork W2980743419 @default.
• W1650596887 hasRelatedWork W2986165042 @default.
• W1650596887 hasRelatedWork W2999108781 @default.
• W1650596887 hasRelatedWork W3211188991 @default.
• W1650596887 hasRelatedWork W873112638 @default.
• W1650596887 hasVolume "1" @default.
• W1650596887 isParatext "false" @default.
• W1650596887 isRetracted "false" @default.
• W1650596887 magId "1650596887" @default.
• W1650596887 workType "article" @default.